Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP‐751 (KT‐6587) or CEP‐701 (KT‐5555)
書誌事項
- タイトル別名
-
- Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555)
収録刊行物
-
- Cancer Res.
-
Cancer Res. 59 (10), 2395-2401, 1999
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1571135651719443712
-
- NII論文ID
- 80011101422
-
- データソース種別
-
- CiNii Articles
- Crossref